Dr. Sunita Tandulwadkar’s journey is a testament to her relentless pursuit of excellence, innovation, and service.

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase III for Peritoneal Cancer.

At Mayo Clinic, researchers published more than 10,000 scientific papers in 2024 that are driving medical discoveries, ...

Novel ADC shows activity in ovarian cancer Towards beta cell replacement therapy for diabetes! An upgraded pluripotent stem cell differentiation protocol is released Lurbinectedin, a new drug for ...

By inhibiting the DNA polymerases, BKC enhances the endogenous RS in cancer cells, leading to increased DNA damage. IBC specifically inhibits CHK2 to prevent DNA repair. The combined use of BKC and ...

R3 new logo R3 Stem Cell is offering highest grade immunotherapy with Natural Killer Cells in Tijuana Mexico. The immu ...

Camarria Williams, a middle-schooler from Chicago discovered a cancer-fighting compound in an unlikely source - goose poop.

When Camarria Williams, 13, stumbled upon goose poop in a neighborhood park, she enthusiastically scooped some up. She and ...

For the first time in the Middle East, Abu Dhabi Stem Cells Centre ... we are advancing cancer and autoimmune treatments using genetically modified immune cells, delivering life-changing care ...